Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.86 - $29.09 $196,614 - $287,991
9,900 New
9,900 $225,000
Q4 2020

Feb 12, 2021

SELL
$34.56 - $57.55 $297,216 - $494,930
-8,600 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$38.36 - $46.91 $329,896 - $403,425
8,600 New
8,600 $344,000
Q1 2019

May 15, 2019

SELL
$26.38 - $33.34 $187,298 - $236,714
-7,100 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$26.66 - $34.85 $189,286 - $247,435
7,100 New
7,100 $212,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.62B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.